Castleview Partners’s Barclays BCS Stock Holding History

Castleview Partners’s Portfolio BCS Stock Details BCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-7,824	Closed	-$756	–	736
2021 Q4	$756	Buy	+7,824	New	+$82.1K	0.01%	441

Other funds holding BCS

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Cambiar Investors Denver, Colorado $2.16B AUM 16.24% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Castleview Partners's BCS Position: Q1 2022 in Review

Castleview Partners sold out of Barclays (BCS) in Q1 2022, closing a stake of 7,824 shares — an estimated $756 sold.

Castleview Partners first reported a position in BCS in Q4 2021 and held it in 1 quarter. The position peaked at $756 in Q4 2021. 302 funds tracked by Wall St. Rank hold BCS as of Q1 2022.

Castleview Partners reported no remaining Barclays position as of Q1 2022 after selling out during the quarter.
Castleview Partners sold 7,824 Barclays shares in Q1 2022, an estimated $756.
Castleview Partners first reported a position in Barclays in Q4 2021 and held it in 1 quarter.
Castleview Partners's Barclays position peaked at $756 in Q4 2021.
302 funds tracked by Wall St. Rank held Barclays as of Q1 2022.

Based on Castleview Partners's 13F filing for Q1 2022, filed 16 May 2022.